The inconsistent levels of mRNA and protein expression in patients with PAAD and liver cancer may stem from an unidentified post-transcriptional regulatory mechanism that hinders the translation of PRKCSH mRNA. This evidence concerns the gene PRKCSH and pancreatic adenocarcinoma.